Digital healthcare company Delve Health has partnered to integrate AliveCor’s EKG device with its LiveCare Link + smart RPM gateway. AliveCor’s KardiaMobile 6L device can be used by patients and ...
RICHFIELD, Wis. - A Richfield GE Healthcare worker designs devices meant to save lives. Wearing it led to his own life-saving diagnosis. Matt Pemberton designs EKG systems, working with a small device ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
A new compact, lightweight, gel-free and waterproof electrocardiogram (ECG) sensor offers more comfort and less skin irritation, compared to similar heart monitoring devices on the market. ECGs help ...
The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending KardiaMobile 6L for measuring cardiac QT interval in people on antipsychotic medication. "It is the ...
NimbleHeart, the Campell, California-based producer of clinical-grade mobile cardiac monitoring devices, announced that its fully reusable ECG device has received FDA clearance and will soon be ...
For just $149, consumers can now carry a personal ECG (electrocardiogram) device in their wallet. FDA cleared AliveCor's KardiaMobile Card, which the Mountain View, CA-based company describes as "the ...
Which EKG monitors are best? With healthcare and hospital systems more understaffed and overworked than ever, the ability to acquire simple medical diagnostic tests has been somewhat reduced.
BELFAST, Northern Ireland--(BUSINESS WIRE)--B-Secur today launched an ECG hardware and software development kit which can help technology companies fast-track the development of their ECG devices.
Adding neuromuscular electrical stimulation to physiotherapy boosts functional performance in hospitalized patients with ...
Dutch trial establishes feasibility of screening approach in routine specialty care ...
The French clinical stage company focused on cardiac innovation received the funds from a Series C funding round and the EC’s Med4Cure innovation fund.